|
CASE REPORT |
|
Year : 2017 | Volume
: 12
| Issue : 1 | Page : 55-56 |
|
A foreign body reaction to Surgicel® in a lymph node diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration |
|
Diana Badenes1, Lara Pijuan2, Víctor Curull1, Albert Sánchez-Font1
1 Department of Pulmonology, Hospital del Mar Parc de Salut Mar, UAB, CIBERES, ISCIII; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain 2 IMIM (Hospital del Mar Medical Research Institute); Department of Pathology, Hospital del Mar Parc de Salut Mar, UAB, Barcelona, Spain
Date of Submission | 24-May-2016 |
Date of Acceptance | 30-Aug-2016 |
Date of Web Publication | 6-Jan-2017 |
Correspondence Address: Albert Sánchez-Font Department of Pulmonology, Endoscopy Unit, Hospital del Mar-Parc de Salut Mar, Passeig Marítim 25-29, Barcelona 08003 Spain
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1817-1737.197780
|
|
Abstract | | |
Surgicel ® (Ethicon, North Ryde, NSW, Australia) is an absorbable sheet of oxidized cellulose polyanhydroglucuronic acid polymer used as an hemostatic in cardiovascular and thoracic surgery. In some cases, the retained material may cause foreign body granulomatous reactions and simulate tumor recurrence, an abscess, an hematoma, or an infection. We report the case of a 55-year-old patient who was operated of a lung adenocarcinoma. In the thoracic computed tomography scan 1 year after the surgery, a right paratracheal lymph node was detected, so endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) was performed suspecting recurrence of the tumor. The cytology results of the lymph node showed a nonnecrotizing granulomatous reaction secondary to Surgicel ® , used as an hemostatic during the surgery. The objective of presenting this case is to consider foreign body reaction to Surgicel ® in the differential diagnosis of postoperative suspicion of neoplastic recurrence, and on the other hand, to note that EBUS-TBNA enables diagnosis.
Keywords: Endobronchial ultrasound-guided transbronchial needle aspiration, foreign body reaction, lung cancer, Surgicel®
How to cite this article: Badenes D, Pijuan L, Curull V, Sánchez-Font A. A foreign body reaction to Surgicel® in a lymph node diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration. Ann Thorac Med 2017;12:55-6 |
How to cite this URL: Badenes D, Pijuan L, Curull V, Sánchez-Font A. A foreign body reaction to Surgicel® in a lymph node diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration. Ann Thorac Med [serial online] 2017 [cited 2023 Mar 25];12:55-6. Available from: https://www.thoracicmedicine.org/text.asp?2017/12/1/55/197780 |
Surgicel ® (Ethicon, North Ryde, NSW, Australia) is an absorbable oxidized cellulose mesh of a vegetal polyanhydroglucuronic acid polymer used in surgery as an hemostatic agent to control small bleeding, to optimize ligatures coagulation, or when electrocoagulation is not enough. [1] It is mainly used in cardiovascular surgery but also in other types of interventions. The material is deposited on the surgical bed and is usually reabsorbed during the following 7-14 days. In recent years, some complications have been described secondary to compression of surrounding anatomic structures causing the formation of granulation tissue as a foreign body reaction. [2] We describe the first case of a surgical patient with a history of pulmonary neoplasia in whom a paratracheal lymph node suspicious of tumor recurrence was detected 1 year after the surgery being diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) of foreign body reaction to Surgicel ® .
Case Report | |  |
We report the case of a 55-year-old patient, active smoker without occupational exposure who, after the discovery of a pulmonary nodule on thoracic computed tomography (CT), underwent a right upper lobectomy with lymphadenectomy that was diagnostic of pulmonary adenocarcinoma (pT1b pN0). All the lymph nodes sampled in the surgery (10R, 11R, 7, 4R, and 9R) presented sinus histiocytosis and anthracosis and were negative for metastasis. Lymph node from region 4R had fragments of bronchial cartilage introduced by EBUS-TBNA performed previously [Figure 1]a. One year later, during outpatient thoracic surgery monitoring, thoracic CT evidenced a low right paratracheal lymph node [Figure 1]b. With the suspicion of pulmonary neoplasm recurrence, EBUS-TBNA was performed [Figure 2]a]. The lymphadenopathy cytology showed a nonnecrotizing granulomatous reaction secondary to amorphous fragments of an acellular material that were birefringent under polarized light, compatible with Surgicel ® [Figure 2]b. The culture and polymerase chain reaction testing for Mycobacterium tuberculosis were negative. At 6 months of follow-up, no significant changes in the lymph node were observed. | Figure 1: (a) Lymph node 4R with sinus histiocytosis, anthracosis, and a piece of bronchial cartilage (H and E, ×4). (b) Thoracic computed tomography axial section showing the right low paratracheal lymph node of 14 mm
Click here to view |
 | Figure 2: (a) Endobronchial ultrasound image showing the right low paratracheal lymph node of 12 mm × 11 mm. (b) Right low paratracheal lymph node puncture. Aggregates of acellular amorphous material (birefringent under polarized light) with foreign body type multinucleated giant cells (Papanicolau, ×20)
Click here to view |
Discussion | |  |
Surgicel ® , an absorbable mesh of polyanhydroglucuronic acid-oxidized cellulose polymer, is used in surgery as an hemostatic agent to control small bleeding, to optimize ligatures coagulation, and when electrocoagulation is not enough. [1] Surgicel ® acts as an anchor for platelets to initiate adhesion, aggregation, and coagulation. [3] Absorption begins at 24 h and depends on the amount of material used. Surgicel ® 's fibrous residue is phagocytized by macrophages 48 h after implantation, although a period of 4-8 weeks is required for it to be completely absorbed. Since it began to be used, cases that simulate tumor recurrence have been described in neurosurgery, gastrointestinal, and cardiac surgery, forcing additional examinations to determine an etiology of foreign body granulomatous reactions. [1],[2],[3],[4] To date, however, there have been no reported cases of suspected recurrence of pulmonary neoplasm.
The dissolution of Surgicel ® depends on the amount used and where along with environmental factors. Only the minimum amount necessary should be used; indeed, most complications reported in the literature are related to an excess of the material. [1] Surgicel ® has an uronic acid component that can increase inflammation of the surrounding tissue and delay healing of the injury. [5] Complicated degradation reactions due to tissue damage can sometimes occur such as provisional matrix formation, acute or chronic inflammation, the appearance of granulation tissue, and creation of foreign body reactions leading to the formation of a fibrous capsule. [3] It is estimated that these reactions occur in about 3% of cases. [5] With current imaging technology, it is not possible to differentiate the accumulation of Surgicel ® from possible tumor recurrence, hematoma, or abscess. In our case, the appearance of a low right paratracheal lymph node led us to suspect a recurrence of lung adenocarcinoma. We carried out EBUS-TBNA to study the lymph node.
Conclusion | |  |
The objective of this case report is to present Surgicel ® , a safe local hemostatic agent used in thoracic surgery, which reduces complications after surgery, and therefore health care costs, [5] which in a small percentage of cases may lead to complications or the appearance of lesions that can simulate abscesses or, as in the present case, nodal tumor recurrence. In this sense, granulomatous reaction to this material should be considered in the differential diagnosis of suspected lung tumor recurrence in surgically treated patients. Finally, EBUS-TBNA was a useful diagnostic approach.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References | |  |
1. | Patanè F, Zingarelli E, Verzini A, di Summa M. Complication due to excessive use of surgicel. Eur J Cardiothorac Surg 2001;20:1034. |
2. | Eto K, Matsumoto M, Kubo Y, Kemmochi R. Superior vena cava syndrome caused by a swollen absorbable haemostat after repair of ischaemic mitral regurgitation. J Cardiothorac Surg 2014;9:1. |
3. | Pierce A, Wilson D, Wiebkin O. Surgicel: Macrophage processing of the fibrous component. Int J Oral Maxillofac Surg 1987;16:338-45. |
4. | Ibrahim MF, Aps C, Young CP. A foreign body reaction to Surgicel mimicking an abscess following cardiac surgery. Eur J Cardiothorac Surg 2002;22:489-90. |
5. | Tomizawa Y. Clinical benefits and risk analysis of topical hemostats: A review. J Artif Organs 2005;8:137-42. |
[Figure 1], [Figure 2] |
|
This article has been cited by | 1 |
Comparison of Efficacy and Safety of Non-Regenerated and Regenerated Oxidized Cellulose Based Fibrous Haemostats |
|
| Petr Habal, Veronika Sívková, Petr Votava | | Acta Medica (Hradec Kralove, Czech Republic). 2022; 65(2): 53 | | [Pubmed] | [DOI] | | 2 |
A lymph node mediastinal foreign body reaction mimicking nodal metastasis: A case series |
|
| Lina Zuccatosta, Maria Agnese Latini, Federico Mei, Martina Bonifazi, Emanuela Barisione, Mario Salio, Stefano Gasparini, Francesca Gonnelli | | Frontiers in Medicine. 2022; 9 | | [Pubmed] | [DOI] | | 3 |
Unusual lymphadenopathy diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration |
|
| Emanuele Stirpe, Floriana Bardaro, Johanna Köhl | | Monaldi Archives for Chest Disease. 2022; | | [Pubmed] | [DOI] | | 4 |
A randomized controlled trial to compare the efficacy of regenerated and non-regenerated oxidized cellulose gauze for the secondary treatment of local bleeding in patients undergoing hepatic resection |
|
| Chengshuo Zhang, Dazhi Fu, Fengshan Wang, Xinping Zhong, Lei Yang, Gang Wu, Baifeng Li, Jialin Zhang | | Annals of Surgical Treatment and Research. 2021; 100(4): 193 | | [Pubmed] | [DOI] | | 5 |
Evaluation and comparison of structurally different cellulose-based hemostatic agents in a rat kidney model |
|
| Alice Paprskárová, Pavel Suchý, Marta Chalupová, Lenka Michlovská, Jarmila Klusáková, Tomáš Sopuch, Lucy Vojtová | | Cellulose. 2021; 28(14): 9369 | | [Pubmed] | [DOI] | | 6 |
Reacción de cuerpo extraño por Surgicel® que simula recaída ganglionar en PET/TC tras cirugía por cáncer de pulmón: 3 nuevos casos |
|
| J. López Sánchez, M.T. Gómez Hernández | | Revista Española de Medicina Nuclear e Imagen Molecular. 2021; 40(3): 202 | | [Pubmed] | [DOI] | | 7 |
Strange body reaction by Surgicel® simulating lymph node relapse on PET/CT after lung cancer surgery: 3 new cases |
|
| J. López Sánchez, M.T. Gómez Hernández | | Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 2021; 40(3): 202 | | [Pubmed] | [DOI] | | 8 |
A Comparative Efficacy Evaluation of Recombinant Topical Thrombin (RECOTHROM®) With A Gelatin Sponge Carrier Versus Topical Oxidized Regenerated Cellulose (TABOTAMP®/SURGICEL®) In A Porcine Liver Bleeding Model |
|
| Paul Slezak, Claudia Keibl, Dirk Labahn, Anna Schmidbauer, Yuri Genyk, Heinz Gulle | | Journal of Investigative Surgery. 2021; 34(8): 862 | | [Pubmed] | [DOI] | | 9 |
EBUS-TBNA Diagnosis of a Granulomatous Reaction to Surgicel® in mediastinal adenopathy |
|
| Jose Manuel Díaz López, Alberto Caballero Vázquez, Javier Luis López Hidalgo, Bélgica Márquez Lobo | | Archivos de Bronconeumología (English Edition). 2020; 56(7): 460 | | [Pubmed] | [DOI] | | 10 |
Diagnóstico mediante EBUS-TBNA de reacción granulomatosa secundaria a Surgicel en adenopatía mediastínica |
|
| Jose Manuel Díaz López, Alberto Caballero Vázquez, Javier Luis López Hidalgo, Bélgica Márquez Lobo | | Archivos de Bronconeumología. 2020; 56(7): 460 | | [Pubmed] | [DOI] | |
|
|
 |
|
|
|
|
|
|
|
Article Access Statistics | | Viewed | 4624 | | Printed | 138 | | Emailed | 0 | | PDF Downloaded | 394 | | Comments | [Add] | | Cited by others | 10 | |
|

|